Skip to main content
€

Or 34,00€ After 66% tax deduction

I make a monthly donation I make an IFI donation
Institutional

ICM and fondation Abeona partner on two artificial intelligence projects that will advance gender equality

Published on: 30/01/2018 Reading time: 1 min
Logo fondation abeona
Retour à la recherche

Men and women face different chronic disease risks. Women, for example, are 1.5 times more likely to develop Alzheimer's disease. Although biological differences, cultural and social factors play a role, we do not fully understand the causes. Data science and artificial intelligence have the potential to improve knowledge and diagnosis on such diseases and enable individualized treatments.

Fondation Abeona and Institut du Cerveau - ICM are joining forces to support two ground-breaking research projects on Multiple Sclerosis and neurodegenerative diseases such as Alzheimer's. This two-year partnership comes into effect as Cédric Villani, a mathematician and member of the French Parliament, is preparing to submit a special report on France’s AI strategy in the next few weeks.

The "two infinities" of medical data: neuro-imaging and genomics

A million pixels in a medical image, a billion codes in a genome: high dimension is a major challenge to data science in medical research.

The second cause of severe disability after traffic accidents, Multiple Sclerosis manifests itself around the age of 30 and affects more than 80 000 people in France (source AP-HP). Three times as many women as men are afflicted. Different factors influence the onset of the disease and its progression.

The MSBioProgress project uses sophisticated statistical techniques to analyze high-dimensional data sets, such as genomic biomarkers and brain images to predict the individual evolution of the disease and propose personalized treatments.

Neurodegenerative disorders, such as Alzheimer's disease, affect millions of people around the world. They progress over several decades before first symptoms appear. The Brain@Scale project develops a new algorithm to better diagnose neurodegenerative diseases from medical images. These two projects are led by researchers at the Institut du Cerveau - ICM's Neuroinformatics Center, which incorporates innovative data science techniques into brain research.

"Medical data poses new challenges to data science. Algorithmic innovation is thus essential to building effective and useful tools for medical research. We particularly appreciate the stimulating support of the Abeona Foundation." Olivier Colliot, research scientist at the Institut du Cerveau - ICM (CNRS) and co-leader of the ARAMIS team (Inria / Institut du Cerveau - ICM), and Violetta Zujovic, researcher at the Institut du Cerveau - ICM in the molecular and cellular approach team of myelin repair.

"We are excited to work with the Institut du Cerveau - ICM researchers and support these two multi-disciplinary projects at the crossroads of genomics, neuro-imaging and data science, as they demonstrate ethical applications of artificial intelligence” Anne Bouverot, President of the Abeona Foundation.

"We are delighted to partner with Fondation Abeona, a young and innovative foundation that has detected these two projects among our most promising ones in this area, and in doing so to promote gender equality, in full alignment with our values.” Professor Alexis Brice, Director General of the Institut du Cerveau - ICM.

Our news on the subject

Un cerveau avec des couleurs
Artificial intelligence and data science: two young international researchers join the Paris Brain Institute
Following a call for applications for junior team leaders in artificial intelligence—which attracted 96 applicants—the Paris Brain Institute has selected two young researchers, Valeria Fascianelli and Jonathan Nicholas, to build their own research...
11.19.2026 Institutional
Des mains qui manipulent
15 ambitious projects from the Paris Brain Institute supported by the ANR
The Paris Brain Institute has just secured 15 grants under the National Research Agency’s (ANR) 2026 General Call for Proposals (AAPG), for a total of 5.5 million euros.
11.06.2026 Institutional
Installation de la Fresque généreuse sur la façade
“Fresque Généreuse”: solidarity takes center stage on the facade of the Paris Brain Institute
On November 2, 2026, to conclude the celebrations marking its 15th anniversary, Serge Weinberg, president of the Paris Brain Institute; Stéphanie Debette, executive director; and Olivier Goy, patron and ambassador of the Institute, unveiled the...
11.06.2026 Events
Maëlys Solal
Maëlys Solal receives the 20th L’Oréal-UNESCO For Women in Science France Award
Maëlys Solal, a postdoctoral researcher in the Aramis team led by Ninon Burgos and Olivier Colliot, has received the 20th L’Oréal-UNESCO For Women in Science France Young Talents Award. The award recognises the excellence of her research at the...
10.08.2026 Institutional
L'équipe Cure-ND4ALS
European CURE-ND alliance launches the CURE-ND4ALS initiative in order to speed up translational research into Charcot’s disease (ALS)
The European CURE-ND alliance has announced the launch of CURE-ND4ALS, an ambitious, patient-focused initiative that seeks to tackle amyotrophic lateral sclerosis (ALS). The program is supported by the Fonds Invincible Été, a philanthropic fund...
05.29.2026 Institutional
Logo Cure-nd
CURE-ND: a structuring European alliance to transform research on neurodegenerative diseases
In an Insight published this Friday, April 17 in The Lancet Neurology, the four partners of the European CURE-ND alliance, including the Institut du Cerveau, present a joint analysis highlighting their shared ambition: to structure an integrated...
04.18.2026 Institutional
See all our news